Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AMRX

AMRX News

Newswire

08:49

Amneal Pharma Reports Positive Interim ELEVATE-PD Study Results

09:55

Amneal Pharma's Generic RESTASIS Approved by FDA for Dry Eye Disease Treatment.

08:22

Amneal Pharmaceuticals receives FDA approval for albuterol inhalation aerosol.

08:06

Amneal Pharmaceuticals to Participate in Investor Conferences in December and January.

16:02

Amneal Pharmaceuticals Announces FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye Syndrome Treatment

View More

About AMRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More